Zobrazeno 1 - 10
of 349
pro vyhledávání: '"Y.M. Kirova"'
Autor:
S. Allali, Alain Fourquet, P. Moguelet, A. Beddok, F. Chasset, Caroline Saint-Martin, Y.M. Kirova
Publikováno v:
Cancer/Radiothérapie. 26:594-598
Data on the incidence and severity of radiation-induced toxicity in patients with systemic and/or cutaneous lupus erythematosus (SLE/CLE) are very limited. After reporting the case of a patient who experienced major toxicity and CLE flare in the irra
Publikováno v:
Cancer/Radiothérapie. 26:542-546
Resume Objectif de l’etude La radiotherapie hypofractionnee moderee est devenue une pratique de routine pour une population selectionnee de patientes traitees pour un cancer du sein de stade precoce. En avril 2020 est publiee l’etude Fast Forward
Autor:
Anne Vincent-Salomon, L. Escalup, Alain Fourquet, Y.M. Kirova, Pierre Loap, S. Ben Dhia, K.I. Cao, Delphine Loirat
Publikováno v:
Cancer/Radiothérapie. 25:424-431
Resume Introduction et but de l’etude La tolerance de l’association d’une radiotherapie concomitante a un traitement par pertuzumab et trastuzumab ) est encore inconnue. L’objectif de ce travail etait d’evaluer la tolerance de cette associa
Publikováno v:
Cancer/Radiothérapie. 24:73-80
Resume L’essor recent de l’immunotherapie a mis en lumiere la complexite des mecanismes de l’immunite anti-tumorale integree a l’oncogenese. Les therapies conventionnelles, essentiellement directement tumoricides, laissent place a des molecul
Publikováno v:
Cancer/Radiothérapie. 23:922-925
The purpose of this work was reducing treatment-related toxicity for Hodgkin lymphomas using practical procedure inspired by the ILROG guidelines. Reporting the first case of localized Hodgkin lymphoma treated with protontherapy in France. A 24-year-
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 26(5)
Intensity-modulated radiotherapy with helical Tomotherapy is a novel radiation therapy technique, which may be beneficial in several features compared to traditional methods. Our aim was to evaluate the local control, overall survival, progression fr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Radiotherapie
The coronavirus disease 2019 (COVID-19) pandemic has caused a global upheaval in our health care system. Our hospital facilities have been subjected to a major influx of patients and the prevention of cross-contamination has been a key issue in the s
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 25(8)
Purpose Protontherapy for mediastinal Hodgkin lymphoma reduces cardiac, lung and breast exposure, which may limit radiation-induced adverse events. While this technique is already widely implemented in the United-States, clinical experience is still
Autor:
B. Deau-Fischer, Didier Bouscary, L. de Forceville, Y.M. Kirova, P. Franchi, T. Cassou Mounat, Alexandre Arsene-Henry
Publikováno v:
Cancer/Radiothérapie. 23:232-239
Hodgkin lymphoma is a highly curable malignancy involving lymph nodes and the lymphatic system. Even at late stage disease, about 70% of patients will be cured with standard first line therapy. For patients who experience relapse or refractory classi